- Home
- TRN vs BCRX Comparison
TRN vs BCRX Comparison
Compare TRN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRN | BCRX |
|---|---|---|
| Founded | 1933 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TRN | BCRX |
|---|---|---|
| Price | $27.98 | $8.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $34.00 | $20.82 |
| AVG Volume (30 Days) | 449.5K | ★ 3.7M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | 85.98 | ★ 381.40 |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $2,156,900,000.00 | $25,186,000.00 |
| Revenue This Year | $1.91 | N/A |
| Revenue Next Year | $15.61 | $12.55 |
| P/E Ratio | $18.59 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.76 | $6.00 |
| 52 Week High | $38.31 | $11.22 |
Technical Indicators
Market Signals| Indicator | TRN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.33 | 46.31 |
| Support Level | $27.53 | $8.79 |
| Resistance Level | $28.89 | $9.31 |
| Average True Range (ATR) | 0.54 | 0.32 |
| MACD | 0.16 | -0.02 |
| Stochastic Oscillator | 46.56 | 40.04 |
Price Performance
Historical ComparisonAbout TRN Trinity Industries Inc.
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.